Table 2 Comparison of demographic and menstruation cycles’ characteristics of the subjects
Variables | Auriculotherapy group (n = 41) | Mefenamic acid group (n = 42) | P value |
|---|---|---|---|
aAge (year, mean ± SDb) | 22.66 ± 2.73 | 22.74 ± 3.08 | 0.904 |
cEducation, n (%) | |||
 Bachelor | 30 (73.2) | 31 (73.8) | 0.994 |
 Masters | 6 (14.6) | 6 (14.3) |  |
 Doctorate | 5 (12.2) | 5 (11.9) |  |
bBMI (kg/m2, mean ± SD) | 22.69 ± 2.38 | 22.83 ± 2.81 | 0.796 |
bAge of menarche (year, mean ± SD) | 12.68 ± 1.45 | 12.83 ± 1.56 | 0.653 |
bAge of onset of dysmenorrhea (year, mean ± SD) | 14.07 ± 1.83 | 13.93 ± 1.67 | 0.706 |
bMenstrual interval (day, mean ± SD) | 28.8 ± 2.41 | 29 ± 2.25 | 0.74 |
bMenstrual duration (day, mean ± SD) | 6.2 ± 0.87 | 6.12 ± 0.99 | 0.713 |
cAmount of menstrual bleeding, n (%) | |||
 Mild | 7 (17.1) | 6 (14.3) | 0.922 |
 Moderate | 28 (68.3) | 29 (69) |  |
 Severe | 6 (14.6) | 7 (16.7) |  |
cLiving in dorms, n(%) | |||
 Yes | 28 (68.3) | 28 (66.7) | 0.871 |
 No | 13 (31.7) | 14 (33.3) |  |
dPainkiller consumption: control cycle, n(%) | |||
 Yes | 38 (92.7) | 40 (95.2) | 0.625 |
 No | 3 (7.3) | 2 (4.8) |  |
cPainkiller consumption: 1st cycle, n(%) | |||
 Yes | 27 (65.9) | 15 (35.7) | 0.006 |
 No | 14 (34.1) | 27 (64.3) |  |
cPainkiller consumption: 2nd cycle, n(%) | |||
 Yes | 27 (65.9) | 15 (35.7) | 0.006 |
 No | 14 (34.1) | 27 (64.3) |  |